A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature
- 1 December 2015
- journal article
- research article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 25 (12) , 2318-2325
Abstract
No abstract availableKeywords
Funding Information
- European College of Neuropsychopharmacology
This publication has 12 references indexed in Scilit:
- A Proposed System for Classifying Psychotropic DrugsJournal of Psychosocial Nursing and Mental Health Services, 2014
- Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysisThe Lancet Psychiatry, 2014
- Antidepressants in Bipolar I Disorder: Never as MonotherapyAmerican Journal of Psychiatry, 2014
- Chlorpromazine versus every other antipsychotic for schizophrenia: A systematic review and meta-analysis challenging the dogma of equal efficacy of antipsychotic drugsEuropean Neuropsychopharmacology, 2014
- A proposal for an updated neuropsychopharmacological nomenclatureEuropean Neuropsychopharmacology, 2014
- Effect of Bitopertin, a Glycine Reuptake Inhibitor, on Negative Symptoms of SchizophreniaJAMA Psychiatry, 2014
- Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for PsychopharmacologyJournal of Psychopharmacology, 2014
- Classifying psychotropic drugs by mode of action and not by target disorderCNS Spectrums, 2013
- Antipsychotics in anxiety disorders: An oxymoron or a reflection of non-adequate nomenclature?European Neuropsychopharmacology, 2011
- Delineation of two drug-responsive anxiety syndromesPsychopharmacology, 1964